HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.
By D. Birnie, W. Sauer, F. Bogun, J. Cooper, D. Culver, C. Duvernoy, M. Judson, J. Kron, D. Mehta, J. Cosedis Nielsen and 4 more. Heart Rhythm, 2014
1,339 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Physiology
View Paper: https://www.semanticscholar.org/paper/5ca48714ab0f66cad4d82fff32c70a7dd050b659
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- E. Crouser
- L. Maier
- K. Wilson
- D. Culver
- A. Morgenthau
- R. Bernstein
- C. Bonham
- E. Chen
Citations in the corpus
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, neutral): “Catheter ablation in conjunction with anti-arrhythmic drugs is an effective palliative therapy for terminating VT storm and eliminating one or more inducible VTs in the majority of patients, but recurrences are common and these patients require ICD backup.(624,625)”
- Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline (2020, positive): “Endomyocardial biopsy, even when aided with electroanatomic mapping guidance, is unreliable for the detection of cardiac sarcoidosis (e.g., z 13% diagnostic yield), and requires specialized equipment and skills, is invasive, and has potentially serious complications (10, 154).”